Elliot W. Ehrich
2016
In 2016, Elliot W. Ehrich earned a total compensation of $3.5M as Executive Vice President, Research and Development and Chief Medical Officer at Alkermes, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $556,499 |
|---|---|
| Option Awards | $1,606,518 |
| Salary | $533,704 |
| Stock Awards | $742,210 |
| Other | $13,275 |
| Total | $3,452,206 |
Ehrich received $1.6M in option awards, accounting for 47% of the total pay in 2016.
Ehrich also received $556.5K in non-equity incentive plan, $533.7K in salary, $742.2K in stock awards and $13.3K in other compensation.
Rankings
In 2016, Elliot W. Ehrich's compensation ranked 2,688th out of 14,075 executives tracked by ExecPay. In other words, Ehrich earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,688 out of 14,075 | 81st |
Division Manufacturing | 923 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 269 out of 1,895 | 86th |
Industry group Drugs | 195 out of 1,538 | 87th |
Industry Pharmaceutical Preparations | 148 out of 1,176 | 87th |
Source: SEC filing on April 13, 2017.
Ehrich's colleagues
We found four more compensation records of executives who worked with Elliot W. Ehrich at Alkermes in 2016.